Company / PP&E (Net)
Baxter International PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.9B
FY2025
5-year range
$2.9B / $5.2B
FY2021-FY2025
Trend
+1.4%
vs FY2024
Sector context
#17 of 132
Health Care
What the data says
Baxter International's pp&e (net) of $2.9B is higher than 87% of companies in the Health Care sector (FY2025). PP&E (Net) returned to growth in FY2025 after 3 years of decline, reaching $2.9B.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of -9.2%. Top quartile in the Health Care sector.
Remained stable around $2.9B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -14.7%
- 5-Year CAGR
- -9.2%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 132This company $2.9B Sector average $1.4B
▼
+102.8% above sector average
Key checks
Key Insights
- 5-year CAGR of -9.2%, indicating a declining trend.
- In FY2025, pp&e (net) increased 1.4% year-over-year.
- Ranks #17 out of 132 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2021.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +1.4% |
| FY2024 | $2.9B | -0.0% |
| FY2023 | $2.9B | -38.8% |
| FY2022 | $4.7B | -9.3% |
| FY2021 | $5.2B | +9.7% |
| FY2020 | $4.7B | +4.7% |
| FY2019 | $4.5B | -1.4% |
| FY2018 | $4.6B | -0.3% |
| FY2017 | $4.6B | +7.0% |
| FY2016 | $4.3B | -2.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026